Oklahoma City, OK, United States of America

Kenneth Hensley

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Oklahoma Medical Research Foundation. Active years: 2002-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Hensley. Retrieved from https://idiyas.com/inventor/kenneth-hensley-a661qcmm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7



Average Co-Inventor Count = 1.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2002-2010

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kenneth Hensley: Innovator in Medical Research

Introduction

Kenneth Hensley is a notable inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of medical research, particularly in the development of compounds for the treatment of inflammatory diseases and cancer. With a total of 3 patents, Hensley's work has the potential to impact various therapeutic areas.

Latest Patents

Hensley's latest patents include innovative compositions and methods aimed at addressing critical health issues. One of his notable inventions is related to lanthionine-related compounds for the treatment of inflammatory diseases. This invention provides compositions comprising lanthionine ketimine derivatives and thiomorpholine dicarboxylic acid derivatives. It also discusses the use of these compounds for the treatment and prevention of diseases affecting the central nervous system, highlighting their anti-oxidant, anti-neuroinflammatory, and neuroprotective activities.

Another significant patent focuses on nitrone inhibition of cancer development. Hensley’s research demonstrates that PBN (α-phenyl-tert-butylnitrone) and its derivatives can significantly reduce preneoplastic nodule development and inhibit hepatocellular carcinoma (HCC) formation. His findings suggest that administering PBN can prevent tumor development in genetically altered cells, offering a promising avenue for cancer prevention.

Career Highlights

Throughout his career, Kenneth Hensley has worked with esteemed institutions such as the Oklahoma Medical Research Foundation and the University of Oklahoma. His research has garnered attention for its innovative approach to tackling complex medical challenges.

Collaborations

Hensley has collaborated with notable colleagues, including Robert A. Floyd and Yashige Kotake. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Kenneth Hensley is a distinguished inventor whose work in medical research has led to valuable innovations in the treatment of inflammatory diseases and cancer. His contributions continue to pave the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…